PI
VIGL

PEAK6 Investments’s Vigil Neuroscience VIGL Stock Holding History

PEAK6 Investments’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$141K Hold
41,486
– – ﹤0.01% 2898
2024
Q2 		$166K Hold
41,486
– – ﹤0.01% 2838
2024
Q1 		$141K Hold
41,486
– – ﹤0.01% 3231
2023
Q4 		$140K Buy
41,486
+17,690
+74% +$91K ﹤0.01% 3420
2023
Q3 		$128K Buy
23,796
+9,459
+66% +$65.3K ﹤0.01% 3298
2023
Q2 		$135K Buy
+14,337
New +$136K ﹤0.01% 3100
2022
Q3 		– Sell
-14,337
Closed -$135K – 6196
2022
Q2 		$135K Buy
+14,337
New +$56.6K ﹤0.01% 5056

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PEAK6 Investments's VIGL Position: Q3 2024 in Review

PEAK6 Investments held its Vigil Neuroscience (VIGL) position steady in Q3 2024 at 41,486 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #2898.

PEAK6 Investments first reported a position in VIGL in Q2 2022 and has held it in 7 quarters since. The position peaked at $166K in Q2 2024. 52 funds tracked by Wall St. Rank hold VIGL as of Q3 2024.

  • PEAK6 Investments held 41,486 shares of Vigil Neuroscience worth $141K as of Q3 2024.
  • PEAK6 Investments left its Vigil Neuroscience share count unchanged in Q3 2024.
  • Vigil Neuroscience made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2898 holding.
  • PEAK6 Investments first reported a position in Vigil Neuroscience in Q2 2022 and has held it in 7 quarters since.
  • PEAK6 Investments's Vigil Neuroscience position peaked at $166K in Q2 2024.
  • 52 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.